Orphan Status Granted in EU For Stargardt Disease, ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells for Treatment of Stargardt's Disease http://www.prnewswire.com/news-releases/act-granted-eu-orphan-medicinal-product-designation-for-hesc-derived-rpe-cells-for-treatment-of-stargardts-disease-124587868.html